Hormone Replacement Therapy and Associated Risk of Stroke in Postmenopausal Women
Arch Int Med 162:1954-1960, Lemaitre,R.N.,et al, 2002

Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women
JAMA 288:2123-2129,2170, Zandi,P.P.,et al, 2002

Treatment of Women with Epilepsy
Seminars in Neurology 22:289-297, Pack.A.M.&Morrell,M.J., 2002

Hormone Replacement Therapy and Reduced Cognitive Decline in Older Women
Neurol 57:2210-2216, Carlson,M.C.,et al, 2001

Long-term Treatment of Acromegaly With Pegvisomant, a Growth Hormone Receptor Antagonist
Lancet 358:1754-1759,1743, van der Lely,A.J.,et al, 2001

Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001

High-Dose Estradiol Improves Cognition for Women with AD, Results of a Randomized Study
Neurol 57:605-612, Asthana,S.,et al, 2001

Postpartum Blindness
Lancet 358:1338, Jurgensen,J.S.,et al, 2001

A Clinical Trial of Estrogen-Replacement Therapy After Ischemic Stroke
NEJM 345:1243-1249, Viscoli,C.M.,et al, 2001

Fomepizole for the Treatment of Methanol Poinsoning
NEJM 344:424-429, Brent,J.,et al, 2001

Hormone Replacement Therapy and Cognition
JAMA 285:1489-1499, LeBlanc,E.S.,et al, 2001

Neuro-Ophthalmic Manifestations of Sarcoidosis. Clincal Spectrum, Evaluation and Management
J Neuroophthalmol 21:132-137, Frohman,L.P,et al, 2001

Adverse Effect of Anticonvulsants on Efficacy of Chemotherapy for Acute Lymphoblastic Leukaemia
Lancet 356:285-290, Relling,M.V. et al, 2000

Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000

Tolcapone and Hepatotoxic Effects
Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000

Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease
JAMA 283:1007-1015,1055, Mulnar,R.A.,et al, 2000

Estrogen for Alzheimer's Disease in Women, Randomized, Double-Blind, Placebo-Controlled Trial
Neurol 54:295-301, Henderson,V.W.,et al, 2000

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Estrogen Use and Early Onset Alzheimer's Disease:A Population-Based Study
JNNP 67:779-781, Slooter,A.J.C.,et al, 1999

The Effect of Estrogen Replacement on Early Parkinson's Disease
Neurol 52:1417-1421, Sanders-Pullman,R.,et al, 1999

Muscle Pain after Exercise
Lancet 353:1062, Nielen,C.&Mazzone,P., 1999

Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998

HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998

Estrogen-replacement Therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging
Neurol 50:996-1002, Baldereschi,M.,et al, 1998

Postmenopausal Estrogen Use and Parkinson's Disease with and without Dementia
Neurol 50:1141-1143, Marder,K.,et al, 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Hematopoietic Stem-Cell Transplantation in Globoid-Cell Leukodystrophy
NEJM 338:1119-1126, Krivit,W.,et al, 1998

Follow-up of Nine Patients with Hurler Syndrome After Bone Marrow Transplantation
J Pediatr 133:119-125, 71998., Guffon,N.,et al, 1998

Ischemic Stroke and Use of Estrogen and Estrogen/Progestogen as Hormone Replacement Therapy
Stroke 29:23-28, Petitti,D.B.,et al, 1998

Cognitive Function in Nondemented Older Women who Took Estrogen after Menopause
Neurol 50:368-373, Jacobs,D.M.,et al, 1998

Estrogen Therapy in Postmenopausal Women, Effects on Cognitive Function and Dementia
JAMA 279:688-695, Yaffe,K.,et al, 1998

Pharmacologic Treatment of Cognition in Alzheimer's Dementia
Neurol 51:S36-S44, Farlow,M.R.&Evans,R.M., 1998

Gabapentin Does Not Interact with a Contraceptive Regimen of Norethindrone Acetate and Ethinyl Estradiol
Neurol 50:1146-1148, Eldon,M.A.,et al, 1998

Drug Treatment of Alzheimer's Disease, Raise Clinical and Ethical Problems
BMJ 314:693-694, Kelley,C.A.,et al, 1997

X Linked Adrenoleukodystrophy:Clinical Presentation, Diagnosis, and Therapy
JNNP 63:4-14, vanGeel,B.M.,et al, 1997

Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter 39:53-54, , 1997

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997

CSF Findings in Children with Lyme Disease-Associated Facial Nerve Palsy
Arch Pediatr Adolesc Med 151:1224-1228, 11831997., Belman,A.L.,et al, 1997

COMT Inhibition with Tolcapone Reduces the"Wearing Off"Phenomenon & Levodopa Requirements in Fluctuating Parkinsonisn Pts
JNNP 63:421-428, Baas,H.,et al, 1997

Tolcapone Improves Motor Function in Parkinsonian Pts with the"Wearing Off"Phenomenon
Neurol 49:1066-1071, Rajput,A.H.,et al, 1997

Entacapone Improves Motor Fluctuations in Levodopa-Treated Parkinson's Dis Pts
Parkinson Study Group, Ann Neurol 42:747-7551997., , 1997

Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997

An Update on Primary Drug Therapies for Alzheimer Disease
Arch Neurol 54:1406-1409, Knopman,D.S.&Morris,J.C., 1997

Use of Low-Dose Oral Contraceptives and Stroke in Young Women
Ann Int Med 127:596-603, Schwartz,S.M.,et al, 1997

Hormone Replacement Therapy and Risk of Non-Fatal Stroke
Lancet 350:1277-1283, Pedersen,A.T.,et al, 1997

A Prospective Study of Estrogen Replacement Therapy and the Risk of Developing Alzheimer's Disease
Neurol 48:1517-1521, Kawas,C.,et al, 1997

A Case of Acute Monocytic Ehrlichiosis with Prominent Neurologic Signs
Neurol 48:1619-1623, Grant,A.C.,et al, 1997

Tolcapone in Stable Parkinson's Disease:Efficacy and Safety of Long-Term Treatment
Neurol 49:665-671, Waters,C.H.,et al, 1997

New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996

Estrogen Replacement Therapy and Risk of Alzheimer Disease
Arch Int Med 156:2213-2217, Paganinni-Hill,A.&Henderson,V.W., 1996